You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 5, February 7, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Measuring Progress Toward Achieving Hemoglobin A1c Goals in Diabetes Care

Pass/Fail or Partial Credit

Leonard Pogach, MD, MBA; Michael Engelgau, MD, MS; David Aron, MD, MS

JAMA. 2007;297:520-523.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Despite increasing recognition of the effect of diabetes on the health of the US population, there has been only modest improvement in glycemic control among most demographic groups from the 1990s to the early 2000s regardless of health care setting.1 Performance measurement should assess quality of care, which is defined by the Institute of Medicine as the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge.2 Consequently, hemoglobin A1c (HbA1c) control is an important intermediate outcome for measuring the quality of care provided to the 21 million Americans with diabetes. However, considerable debate exists concerning which HbA1c levels are appropriate for public reporting when quality assessments are compared across multiple health care systems.

It is important to distinguish between practice guidelines and performance . . . [Full Text of this Article]

Author Affiliations: New Jersey Veterans Healthcare System, East Orange (Dr Pogach); University of Medicine and Dentistry of New Jersey, Newark (Dr Pogach); Centers for Disease Control and Prevention, Atlanta, Ga (Dr Engelgau); and Louis Stokes Cleveland Veterans Affairs Medical Center and Case School of Medicine, Case Western Reserve University, Cleveland, Ohio (Dr Aron).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Revisiting Screening for Type 2 Diabetes Mellitus: To Screen or Not to Screen, That Is the Question-Reply-II
Lawler
Mayo Clin Proc. 2009;84:385-386.
FULL TEXT  

Quality indicators for diabetes mellitus in the ambulatory setting: using the Delphi method to inform performance measurement development
Aron and Pogach
Qual Saf Health Care 2008;17:315-317.
FULL TEXT  

Mitigating Case Mix Factors by Choice of Glycemic Control Performance Measure Threshold
Bainbridge et al.
Diabetes Care 2008;31:1754-1760.
ABSTRACT | FULL TEXT  

Oral Hypoglycemics and Diabetic Nephropathy
Hadler
CJASN 2008;3:159-162.
FULL TEXT  

Making performance indicators work: experiences of US Veterans Health Administration
Kerr and Fleming
BMJ 2007;335:971-973.
FULL TEXT  

"Doctor, How Certain Are We That This Diabetes Medication Is Best for Me?"
Pogach
ANN INTERN MED 2007;147:428-430.
FULL TEXT  

Rosiglitazone and Cardiovascular Risk
Bracken et al.
NEJM 2007;357:937-940.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.